March 13, 2018 Comments Off on New tentative approval for Watson Labs drug dienogest; estradiol valerate Posted in: Tentative Approval Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this compound. This ingredient…
The post New tentative approval for Watson Labs dr…
Like this:
Like Loading...
March 13, 2018 Comments Off on Generic companies with the most tentative approvals Posted in: Infographic This chart shows the pharmaceutical companies with the most tentative generic drug approvals in 2017 The Food and Drug Administration (FDA) grants tentative approvals to generic entrants when their generic…
The post Generic companies with the mos…
Like this:
Like Loading...
Health care costs in the US touched a staggering $3.2 trillion in 2015, which makes it one of the nation’s largest industries, equaling 17.8% of gross domestic product. This translates…
The post Factors driving healthcare costs in the US appeared…
Like this:
Like Loading...
March 11, 2018 Comments Off on Drug Patent Expirations for the Week of March 11, 2018 Posted in: Uncategorized
NIASPAN (niacin) Abbvie Patent: 6,469,035 Expiration: Mar 15, 2018 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Dr…
Like this:
Like Loading...
March 11, 2018 Comments Off on New tentative approval for Watson Labs drug dienogest; estradiol valerate Posted in: Tentative Approval Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this compound. This ingredient…
The post New tentative approval for Watson Labs dr…
Like this:
Like Loading...
March 11, 2018 Comments Off on Pharmaceutical companies with the most ‘New Patient Population’ drugs Posted in: Infographic This chart shows the companies which have received the most New Patient Population exclusivities in the past five years. New Patient Populations are one of the categories for which the…
The post Pharmaceutical companies with the most ‘New P…
Like this:
Like Loading...
March 10, 2018 Comments Off on New patent for Genzyme Corp drug CAPRELSA Posted in: Patent Added Annual Drug Patent Expirations for CAPRELSA Caprelsa is a drug marketed by Genzyme Corp and is included in one NDA. It is available from two suppliers. There are two patents…
The post New patent for Genzyme Corp drug CAPRELSA appeared first on Dr…
Like this:
Like Loading...
March 10, 2018 Comments Off on New patent expiration for Mylan Institutional drug ULTIVA Posted in: Uncategorized
Annual Drug Patent Expirations for ULTIVA Ultiva is a drug marketed by Mylan Institutional and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent expiration for Mylan Institutional drug ULTIVA appe…
Like this:
Like Loading...
March 10, 2018 Comments Off on New tentative approval for Watson Labs drug dienogest; estradiol valerate Posted in: Tentative Approval Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this compound. This ingredient…
The post New tentative approval for Watson Labs dr…
Like this:
Like Loading...
March 10, 2018 Comments Off on Generic companies with the most tentative approvals Posted in: Infographic This chart shows the pharmaceutical companies with the most tentative generic drug approvals in 2017 The Food and Drug Administration (FDA) grants tentative approvals to generic entrants when their generic…
The post Generic companies with the mos…
Like this:
Like Loading...